Joint Molecule Formation During Recombination
重组过程中联合分子的形成
基本信息
- 批准号:9768481
- 负责人:
- 金额:$ 29.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-05-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAllelesAuxinsAzidesBiological AssayBiotinCell divisionCell physiologyCellsChemicalsChemistryChromosome PairingChromosomesClosure by clampCoupledCytologyDNADNA Double Strand BreakDNA RepairDNA Replication FactorDNA TopoisomerasesDNA biosynthesisDNA replication forkDefectDeoxyuridineDiseaseElectrophoresisEventGeneticGenetic Crossing OverGenetic RecombinationGerm CellsHomologous GeneHumanImmunofluorescence ImmunologicInfertilityJointsKnowledgeLabelLigationMeasurementMeasuresMeiosisMeiotic RecombinationModelingMolecular GeneticsMonitorMusNaturePathologyPhosphotransferasesPlayPopulationPredictive FactorPregnancy lossProcessProphaseProteinsReactionRegulationRoleS PhaseSLC19A1 geneSaccharomycetalesSister ChromatidSiteSouthern BlottingStreptavidinSurgical FlapsSystemTestingTimeanalogchromosome replicationcohesionconditional mutantegghelicasehomologous recombinationin vivoinnovationinsightinterestmutantpredictive modelingrecruitrepairedsegregationsperm celltooltwo-dimensional
项目摘要
Summary/Abstract
Homologous recombination is a chromosome repair process that plays essential roles in meiosis, the
specialized cell division that produces gametes. Defects in meiotic recombination are a leading cause of
infertility, pregnancy loss and congenital disease in humans. A major gap in our understanding of meiotic
recombination is the mechanism of the recombination-associated DNA synthesis (RADS) that is essential to
restore chromosome integrity. This knowledge gap persists because of inherent challenges to studying meiotic
RADS in vivo, in particular the essential nature of DNA replication factors, the need to study RADS in isolation
from chromosomal replication, and the requirement for special assays to measure RADS. These hurdles have
now been overcome using an innovative combination of chemical, real-time and molecular genetics tools in
budding yeast that enable acute inactivation of essential replication factors specifically during recombination,
and measurement of de novo DNA synthesis. This system utilizes an ATP-analog sensitive allele of the Cdc7
kinase (cdc7-as3) to synchronize cells after S-phase, but before recombination is initiated. Real-time
inactivation of essential replication factors is achieved using the auxin-inducible degron (AID) system, which
has been rewired and optimized for use in meiotic cells. To monitor RADS, newly synthesized DNA is labeled,
isolated and quantified using 5-ethynyl-2′-deoxyuridine (Edu) incorporation, biotin-azide click chemistry,
streptavidin purification and quantitative PCR (qPCR). Exploiting these tools, the long-term objectives of this
project are to understand the nature, function, mechanism and regulation of RADS. These objectives will be
pursued through three aims. Aim 1 will determine the role of RADS for both the DNA events of meiotic
recombination and the chromosomal events of meiotic prophase using the comprehensive battery of
molecular, genetic and cytological assays uniquely available in budding yeast. Aim 2 will test models of RADS
by delineating the replication factors involved and systematically analyzing their roles. Complementary studies
in mouse will analyze the localization and dynamics of replication factors at sites of recombination. Aim 3 will
identify and characterize factors involved in the recruitment of replication factors to recombination sites and the
regulation of RADS. Immunofluorescence cytology will be used to monitor chromosomal dynamics of
replication factors and determine the genetic requirements for their localization. The timing and extent of RADS
will be analyzed in strains mutant for factors predicted to modulate RADS, including meiosis-specific
recombination proteins, DNA helicases and topoisomerases. The results of these aims will provide
unprecedented insights into the mechanism and regulation of RADS, filling a major gap in our understanding of
meiotic recombination. These findings will be germane to understanding pathologies associated with human
meiosis, and are expected to define paradigms that are broadly relevant for chromosome repair.
摘要/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NEIL HUNTER其他文献
NEIL HUNTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NEIL HUNTER', 18)}}的其他基金
FASEB SRC: The Genetic Recombination and Genome Rearrangements
FASEB SRC:基因重组和基因组重排
- 批准号:
10539414 - 财政年份:2022
- 资助金额:
$ 29.35万 - 项目类别:
Meiosis, SUMOylation and the ZIP3 Protein: Parallel Studies in Mouse and Yeast.
减数分裂、SUMOylation 和 ZIP3 蛋白:小鼠和酵母的平行研究。
- 批准号:
8265904 - 财政年份:2009
- 资助金额:
$ 29.35万 - 项目类别:
Meiosis, SUMOylation and the ZIP3 Protein: Parallel Studies in Mouse and Yeast.
减数分裂、SUMOylation 和 ZIP3 蛋白:小鼠和酵母的平行研究。
- 批准号:
8042607 - 财政年份:2009
- 资助金额:
$ 29.35万 - 项目类别:
Meiosis, SUMOylation and the ZIP3 Protein: Parallel Studies in Mouse and Yeast.
减数分裂、SUMOylation 和 ZIP3 蛋白:小鼠和酵母的平行研究。
- 批准号:
7786961 - 财政年份:2009
- 资助金额:
$ 29.35万 - 项目类别:
Joint Molecule Resolution During Meiotic Recombination
减数分裂重组过程中的联合分子解析
- 批准号:
10522961 - 财政年份:2005
- 资助金额:
$ 29.35万 - 项目类别:
Joint Molecule formation during meiotic recombination
减数分裂重组过程中联合分子的形成
- 批准号:
7221897 - 财政年份:2005
- 资助金额:
$ 29.35万 - 项目类别:
Joint Molecule formation during meiotic recombination
减数分裂重组过程中联合分子的形成
- 批准号:
6907652 - 财政年份:2005
- 资助金额:
$ 29.35万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 29.35万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 29.35万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 29.35万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 29.35万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 29.35万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 29.35万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 29.35万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 29.35万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 29.35万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 29.35万 - 项目类别:
Research Grant














{{item.name}}会员




